Understand the source comparison
Dihexa Mechanism of Action Detailed: Comparison to Other Cognitive Enhancers
Dihexa HGF/c-Met agonism → PI3K/Akt activation Synaptogenesis (new synapse formation) 7–14 days for measurable spine density increase Yes. Dendritic spine proliferation, PSD-95 upregulation The only small-molecule HGF mimetic with published synaptogenesis data
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dihexa
- HGF/c-Met agonism → PI3K/Akt activation
- Synaptogenesis (new synapse formation)
- 7–14 days for measurable spine density increase
- Yes. Dendritic spine proliferation, PSD-95 upregulation
- The only small-molecule HGF mimetic with published synaptogenesis data; mechanism is structurally restorative, not modulatory
- Noopept
- AMPA receptor modulation, NGF/BDNF upregulation
- Enhanced glutamatergic transmission
- 30–60 minutes (acute effects)
- Minimal. Primarily functional, not structural
- Effective neuromodulator with neuroprotective properties; does not induce new synapse formation
- Semax
- Melanocortin receptor agonism, BDNF expression
- Neuroprotection, enhanced BDNF signaling
- 2–4 hours
- Indirect. BDNF-mediated plasticity
- Strong neuroprotective profile; supports existing synaptic health but lacks direct synaptogenic mechanism
- Cerebrolysin
- Neurotrophic peptide mixture (BDNF-like activity)
- Neuroprotection, synaptic stabilization
- Days to weeks (chronic administration)
- Moderate. Supports dendritic health, unclear synaptogenesis
- Clinically studied for stroke and dementia; mechanism includes neurotrophic support but not pure synaptogenesis
- Racetams (Piracetam, Aniracetam)
- AMPA receptor potentiation, membrane fluidity
- Enhanced cholinergic and glutamatergic signaling
- 1–3 hours
- No. Purely functional modulation
- First-generation nootropics; reliable neuromodulation without structural synaptic changes